eMedicine Specialties > Ophthalmology > Conjunctiva

Conjunctivitis, Neonatal

Author: Kalpana K Jatla, MD, Private Practice, Clarity Eye Center
Coauthor(s): Robert William Enzenauer, MD, MPH, Professor, Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center; Feng Zhao, MD, PhD, Staff Physician, Department of Ophthalmology, Emory Cartersville Medical Center
Contributor Information and Disclosures

Updated: Nov 17, 2008

Introduction

Background

By definition, neonatal conjunctivitis presents during the first month of life and may be aseptic or septic.

Aseptic neonatal conjunctivitis most often is a chemical conjunctivitis that is induced by silver nitrate solution, which is used for prophylaxis of infectious conjunctivitis. Chemical conjunctivitis is not as common anymore because of the use of erythromycin ointment in place of silver nitrate solution for the prophylaxis of infectious conjunctivitis.

Bacterial, chlamydial, and viral infections are major causes of septic neonatal conjunctivitis, Chlamydia being the most common infectious agent. Infants may acquire these infective agents as they pass through the birth canal during the birth process.

Pathophysiology

The conjunctiva (a thin translucent mucous membrane) can be divided into palpebral, bulbar, and fornical, based on the location. The conjunctiva contains nonkeratinizing, squamous epithelium and a thin, richly vascularized substantia propria (containing lymphatic vessels and cells, such as lymphocytes, plasma cells, mast cells, and macrophages). The conjunctiva also has accessory lacrimal glands and goblet cells.

The pathology of neonatal conjunctivitis is influenced by the anatomy of the conjunctival tissues in the newborn. The inflammation of conjunctiva may cause blood vessel dilation, chemosis, and excessive secretion. This reaction tends to be more serious due to the following: lack of immunity, absence of lymphoid tissue in the conjunctiva, and absence of tears at birth.

Frequency

United States

The incidence of infectious neonatal conjunctivitis ranges from 1-2%, depending on the socioeconomic character of the area.

The epidemiology of neonatal conjunctivitis has changed since silver nitrate solution was introduced to prevent gonococcal ophthalmia.

Chlamydia has been reported as the most common infectious agent that causes ophthalmia neonatorum in the United States (incidence is 6.2 per 1000 live births).

In contrast, the incidence of gonococcal ophthalmia neonatorum has been reduced dramatically, from 100 per 1000 live births to 3 per 1000 live births.

International

As in the United States, incidence of ophthalmia neonatorum in many other countries also decreased after silver nitrate solution was used.

In Europe, incidence fell from 10% of births to less than 1%.

The incidence was less than 7 per 1000 live births in 1943 in England.

A higher incidence of ophthalmia neonatorum exists in developing countries. In a Nairobi hospital, the incidences of gonococcal and chlamydial conjunctivitis were 40 per 1000 and 80 per 1000 (per live newborn), respectively. More than 50% of newborns in Nairobi had concurrent gonococcal conjunctivitis. Prophylaxis was not administered at birth in this area. The prevalence of gonorrhea also was high among antenatal attenders in African countries, ranging from 4-15%.

Mortality/Morbidity

Mortality is due to systemic involvement. No published information is available on mortality.

Antibiotics have significantly altered the prognosis of neonatal conjunctivitis, especially with Neisseria gonorrhoeae infection. A previous study showed that from 1906-1911, 24% of children who were admitted to American schools for the blind had a visual disability that resulted from ophthalmia neonatorum. In contrast, only 0.3% of these children were blind secondary to gonococcal conjunctivitis from 1958-1959.

Race

No published information is available on racial differences.

Sex

No published information is available on sex differences.

Age

This condition presents during the first month of life.

Clinical

History

Although clinical presentations vary with etiology, it is difficult to determine the exact cause of neonatal conjunctivitis on clinical grounds alone. Significant overlap in clinic presentations may be present.

  • Incubation period
    • Chemical conjunctivitis secondary to silver nitrate solution application usually occurs in the first day of life, disappearing spontaneously within 2-4 days.
    • Gonococcal conjunctivitis tends to occur 3-5 days after birth but can present later.
    • Chlamydial conjunctivitis usually has a later onset than gonococcal conjunctivitis; the incubation period is 5-14 days.
    • The incubation period for other nongonococcal, nonchlamydial conjunctivitis is longer, according to a previous report.
    • Herpetic conjunctivitis usually occurs within the first 2 weeks after birth.
  • Clinical presentation of gonococcal conjunctivitis
    • Gonococcal conjunctivitis tends to be more severe than other causes of ophthalmia neonatorum; there is a classic presentation of purulent conjunctivitis, which usually is bilateral.
    • Corneal involvement has been reported, including diffuse epithelial edema and ulceration that may progress to perforation of the cornea and endophthalmitis.
    • Patients also may have systemic manifestations (eg, rhinitis, stomatitis, arthritis, meningitis, anorectal infection, septicemia).
  • Clinical presentation of chlamydial conjunctivitis
    • The presentation of chlamydial conjunctivitis may range from mild hyperemia with scant mucoid discharge to eyelid swelling, chemosis, and pseudomembrane formation.
    • Blindness, although rare and much slower to develop than in gonococcal conjunctivitis, is not due to corneal involvement as in gonococcal conjunctivitis; eyelid scarring and pannus (as in trachoma) cause it.
    • A follicular reaction does not occur because newborns have no requisite lymphoid tissue present in the conjunctiva.
    • Like gonococcal conjunctivitis, chlamydial conjunctivitis also may be associated with extraocular involvement, including pneumonitis, otitis, and pharyngeal and rectal colonization.
  • Clinical presentation of neonatal conjunctivitis due to other agents
    • Neonatal conjunctivitis due to other microbial agents usually is milder.
    • Herpes simplex keratoconjunctivitis usually presents in infants with generalized herpes simplex with corneal epithelial involvement or vesicles on the skin (which surround the eye). Serious systemic complications, such as encephalitis, may occur in these neonates due to their poor immunologic response.

Physical

Presentations for different organisms may vary. Typical findings may include erythema and edema of the eyelids and palpebral conjunctiva and/or purulent eye discharge during the external eye exam. Perform a Gram stain conjunctival smear in all cases.

  • Chemical conjunctivitis
    • The clinical picture of chemical conjunctivitis is mild, transient tearing and conjunctival injection.
    • If the 1% silver nitrate used for neonatal conjunctivitis is provided in a large bottle, the solution can evaporate and become concentrated over time. More concentrated silver nitrate solution may result in more severe responses (eg, lid edema, chemosis, exudate, membranes or pseudomembranes, permanent damage to the conjunctiva or the cornea). This problem is obviated by using sealed, single-use ampules. Chemical conjunctivitis is becoming less common because of the substitution of erythromycin ointment in place of silver nitrate.
  • Chlamydial conjunctivitis
    • Patients typically present with unilateral or bilateral watery discharge, which may become more copious and purulent later.
    • Although most cases are mild and self-limited, it occasionally may be severe. Pseudomembranes, thickened palpebral conjunctiva, significant peripheral pannus, and/or corneal opacification may be present.
  • Gonococcal conjunctivitis
    • This type of conjunctivitis is the most serious, usually occurring 24-48 hours following birth. Typically, patients develop a hyperacute conjunctivitis, associated with marked lid edema, chemosis, and purulent discharge.
    • A conjunctival membrane may be present.
    • Corneal ulcer may occur and rapidly progress to perforation, if treatment is delayed.
  • Other bacterial conjunctivitis
    • Various organisms (eg, gram-positive and gram-negative bacteria) have been identified.
    • Classic clinical pictures are lid edema, conjunctival injection, chemosis, and discharge, which are variable and often indistinguishable from signs of other etiologies.
    • Although it rarely causes neonatal conjunctivitis, Pseudomonas can lead to devastating consequences, such as rapid progression to corneal ulceration and perforation; if left untreated, it even can lead to endophthalmitis and subsequent death.
  • Herpetic conjunctivitis
    • This type typically occurs within the first 2 weeks after birth.
    • Ocular involvement may follow systemic herpes infection or vesicular lesions on the skin or lid margins.
    • Patients may present with nonspecific lid edema, moderate conjunctival injection, and nonpurulent and often serosanguineous discharge, which may be unilateral or bilateral.
    • Microdendrites or geographic ulcers, rather than typical dendrites as seen in adults, are the most typical signs of herpetic keratitis in newborns.
    • Conjunctival membrane may be present.

Causes

The etiology can be chemical or microbial. Although several noninfectious and infectious agents can inflame the conjunctiva, the more common causes are silver nitrate chemical conjunctivitis and chlamydial, gonococcal, staphylococcal, and herpetic infections.

  • Silver nitrate solution
    • In 1881, Crede's method of instilling a drop of 2% silver nitrate into a newborn's eyes was a major advance in preventing neonatal conjunctivitis.
    • Silver nitrate is a surface-active chemical, facilitating agglutinate gonococci and inactivating them. Ironically, silver nitrate was later found to be toxic to the conjunctiva, potentially causing a sterile neonatal conjunctivitis.
  • Chlamydia trachomatis
    • This obligate intracellular parasite has been identified as the most common infectious cause of neonatal conjunctivitis.
    • The reservoir of the organism is the maternal cervix or urethra. Infants who are born to infected mothers are at high risk for developing an infection.
  • Neisseria gonorrhoeae
    • This gram-negative diplococcus is potentially the most dangerous and virulent infectious cause of neonatal conjunctivitis.
    • Gonococci have the ability to penetrate intact epithelial cells and to divide rapidly inside the epithelial cells.
    • Gonorrheal conjunctivitis must be absolutely excluded in every case of neonatal conjunctivitis to avoid serious consequences.
  • Other bacteria
    • The most commonly identified gram-positive organisms include Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus viridans, and Staphylococcus epidermidis.
    • Gram-negative organisms, such as Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Proteus, Enterobacter, and Pseudomonas species, also have been implicated.
  • Herpes simplex
    • Herpes simplex virus (HSV) can cause neonatal keratoconjunctivitis, but it is rare and is associated most often with a generalized herpes simplex infection.
    • Most infants with such infection acquire the disease during the birth process. Therefore, caesarean delivery usually is considered when active genital disease is recognized at term.

More on Conjunctivitis, Neonatal

Overview: Conjunctivitis, Neonatal
Differential Diagnoses & Workup: Conjunctivitis, Neonatal
Treatment & Medication: Conjunctivitis, Neonatal
Follow-up: Conjunctivitis, Neonatal
Multimedia: Conjunctivitis, Neonatal
References

References

  1. Peter G, ed. Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 1997:266-603.

  2. Armstrong JH, Zacarias F, Rein MF. Ophthalmia neonatorum: a chart review. Pediatrics. Jun 1976;57(6):884-92. [Medline].

  3. Barsam PC. Specific prophylaxis of gonorrheal ophthalmia neonatorum. A review. N Engl J Med. Mar 31 1966;274(13):731-4. [Medline].

  4. Credé. Reports from the obstetrical clinic in Leipzig. Prevention of eye inflammation in the newborn. Am J Dis Child. Jan 1971;121(1):3-4. [Medline].

  5. de Toledo AR, Chandler JW. Conjunctivitis of the newborn. Infect Dis Clin North Am. Dec 1992;6(4):807-13. [Medline].

  6. Fransen L, Klauss V. Neonatal ophthalmia in the developing world. Epidemiology, etiology, management and control. Int Ophthalmol. Jan 1988;11(3):189-96. [Medline].

  7. Fransen L, Nsanze H, Klauss V, et al. Ophthalmia neonatorum in Nairobi, Kenya: the roles of Neisseria gonorrhoeae and Chlamydia trachomatis. J Infect Dis. May 1986;153(5):862-9. [Medline].

  8. Fransen L, Van den Berghe P, Mertens A, et al. Incidence and bacterial aetiology of neonatal conjunctivitis. Eur J Pediatr. Mar 1987;146(2):152-5. [Medline].

  9. Friendly DS. Ophthalmia neonatorum. Pediatr Clin North Am. Dec 1983;30(6):1033-42. [Medline].

  10. Hammerschlag MR. Neonatal conjunctivitis. Pediatr Ann. Jun 1993;22(6):346-51. [Medline].

  11. Hammerschlag MR, Cummings C, Roblin PM, et al. Efficacy of neonatal ocular prophylaxis for the prevention of chlamydial and gonococcal conjunctivitis. N Engl J Med. Mar 23 1989;320(12):769-72. [Medline].

  12. Handsfield HH, Hodson WA, Holmes KK. Neonatal gonococcal infection. I. Orogastric contamination with Neisseria gonorrhoea. JAMA. Aug 13 1973;225(7):697-701. [Medline].

  13. Isenberg SJ, Apt L, Yoshimori R, et al. Source of the conjunctival bacterial flora at birth and implications for ophthalmia neonatorum prophylaxis. Am J Ophthalmol. Oct 15 1988;106(4):458-62. [Medline].

  14. Laga M, Plummer FA, Nzanze H, et al. Epidemiology of ophthalmia neonatorum in Kenya. Lancet. Nov 15 1986;2(8516):1145-9. [Medline].

  15. Meheus A, Piot P. Provision of services for sexually transmitted diseases in developing countries. In: Oriel JD, Harris JRW, eds. Recent Advances in Sexually Transmitted Diseases. Churchill Livingstone; 1986:261-271.

  16. Moore BD. Inflammatory and traumatic eye disease in children. In: Eye Care for Infants and Young Children. Butterworth-Heinemann Medical; 1997:246-261.

  17. Nelson LB. Disorders of the conjunctiva. In: Harley's Pediatric Ophthalmology. WB Saunders Co; 1998:202-214.

  18. O'Hara MA. Ophthalmia neonatorum. Pediatr Clin North Am. Aug 1993;40(4):715-25. [Medline].

  19. Oriel JD. Ophthalmia neonatorum: relative efficacy of current prophylactic practices and treatment. J Antimicrob Chemother. Sep 1984;14(3):209-19. [Medline].

  20. Preece PM, Anderson JM, Thompson RG. Chlamydia trachomatis infection in infants: a prospective study. Arch Dis Child. Apr 1989;64(4):525-9. [Medline].

  21. Rapoza PA, Chandler JW. Neonatal conjunctivitis: diagnosis and treatment. American Academy of Ophthalmology: Focal Points. Vol 1. 1988:1-11.

  22. Rothenberg R. Ophthalmia neonatorum due to neisseria gonorrhoeae: prevention and treatment. Sex Transm Dis. Apr-Jun 1979;6(2 Suppl):187-91. [Medline].

  23. Rowe DS, Aicardi EZ, Dawson CR, et al. Purulent ocular discharge in neonates: significance of Chlamydia trachomatis. Pediatrics. Apr 1979;63(4):628-32. [Medline].

  24. Sandström I. Etiology and diagnosis of neonatal conjunctivitis. Acta Paediatr Scand. Mar 1987;76(2):221-7. [Medline].

  25. Sandström KI, Bell TA, Chandler JW, et al. Microbial causes of neonatal conjunctivitis. J Pediatr. Nov 1984;105(5):706-11. [Medline].

  26. Taylor DC. Ophthalmia neonatorum. Pediatric Ophthalmology. Blackwell Science: 1990:103-106.

  27. Whitley RJ, Nahmias AJ, Soong SJ, et al. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics. Oct 1980;66(4):495-501. [Medline].

  28. Whitley RJ, Nahmias AJ, Visintine AM, et al. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics. Oct 1980;66(4):489-94. [Medline].

  29. Wright KW. Conjunctivitis. In: Pediatric Ophthalmology and Strabismus. Mosby Inc; 1995:279-292.

Further Reading

Keywords

neonatal conjunctivitis, ophthalmia neonatorum, infectious conjunctivitis, conjunctiva

Contributor Information and Disclosures

Author

Kalpana K Jatla, MD, Private Practice, Clarity Eye Center
Kalpana K Jatla, MD is a member of the following medical societies: American Academy of Ophthalmology
Disclosure: Nothing to disclose.

Coauthor(s)

Robert William Enzenauer, MD, MPH, Professor, Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center
Robert William Enzenauer, MD, MPH is a member of the following medical societies: American Academy of Ophthalmology
Disclosure: Hamilton County Medical Society Salary Consulting

Feng Zhao, MD, PhD, Staff Physician, Department of Ophthalmology, Emory Cartersville Medical Center
Feng Zhao, MD, PhD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, and International Society of Refractive Surgery
Disclosure: Nothing to disclose.

Medical Editor

Gerhard W Cibis, MD, Clinical Professor, Director of Pediatric Ophthalmology Service, Department of Ophthalmology, University of Kansas, Kansas City
Gerhard W Cibis, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, and American Ophthalmological Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles
Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Managing Editor

Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Jefferson Medical College of Thomas Jefferson University; Co-Chairman of the Cornea Service, Co-Chairman of Refractive Surgery Department, Wills Eye Institute
Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Eye Bank Association of America, Pennsylvania Medical Society, and Philadelphia County Medical Society
Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; Inspire Honoraria Speaking and teaching; RPS Ownership interest Other

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.